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ABSTRACT: Protein stabilization is fundamental to enzyme
function and evolution, yet understanding the determinants of
a protein’s stability remains a challenge. This is largely due to a
shortage of atomically detailed models for the ensemble of
relevant protein conformations and their relative populations.
For example, the M182T substitution in TEM β-lactamase, an
enzyme that confers antibiotic resistance to bacteria, is
stabilizing but the precise mechanism remains unclear. Here,
we employ Markov state models (MSMs) to uncover how
M182T shifts the distribution of diﬀerent structures that TEM
adopts. We ﬁnd that M182T stabilizes a helix that is a key
component of a domain interface. We then predict the eﬀects
of other mutations, including a novel stabilizing mutation, and experimentally test our predictions using a combination of stability
measurements, crystallography, NMR, and in vivo measurements of bacterial ﬁtness. We expect our insights and methodology to
provide a valuable foundation for protein design.
■ INTRODUCTION
Studying the evolution of antibiotic resistance has providedmany
insights into how proteins acquire new functions, but the
mechanistic basis for how mutations alter a protein’s activity and
stability often remains unclear. For example, studying how
bacteria evolve variants of TEM β-lactamase that confer
resistance to new antibiotics by degrading these drugs has
revealed that many of the mutations that give rise to new
functions are destabilizing. Therefore, it is common for proteins
to acquire one or more mutations that alter their function and
then to acquire additional mutations that restore stability.1
M182T is one such stabilizing mutation in TEM, and it has
appeared in numerous clinical isolates and directed evolution
experiments.2−4 This substitution occurs far from the active site
(Figure 1A) and, on its own, has little eﬀect on TEM’s activity. It
is often called a global suppressor because of its ability to
counterbalance the destabilizing eﬀects of a wide variety of other
substitutions that do alter TEM’s activity.3 Despite over two
decades of work on this variant, themechanism of stabilization by
M182T is not understood well enough to predict new stabilizing
mutations. Elucidating the mechanism underlying this stabiliza-
tion would provide a basis for predicting other global suppressors
and eventually developing quantitative design principles.
A mechanistic understanding of how M182T stabilizes TEM
remains elusive because of a lack of methods that provide both a
detailed structural model of the relevant species and their relative
populations. Spectroscopic studies have revealed that TEM-1,
which we will refer to as wild-type TEM, populates at least three
states at equilibrium: a native state (N), an intermediate state (I),
and an unfolded state (U).5 Introducing the M182T substitution
appears to reduce the number of equilibrium states to two.4
However, there is debate over whether this results from M182T
stabilizing the native state or destabilizing the intermediate.6
Moreover, these spectroscopic experiments do not directly
provide a structural model for how M182T shifts the relative
populations of these states. Two competing structural models
based on crystallographic data have been proposed to explain
M182T’s ability to stabilize the enzyme. In the ﬁrst model,
Thr182 is poised to form a hydrogen bond between TEM’s two
structural domains, interacting with the backbone carbonyls of
Glu63 and Glu64 in an adjacent loop7 (Figure 1B). Therefore, it
was proposed that M182T stabilizes TEM by strengthening the
interface between the α-helix and β-sheet domains. However, in a
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later structure, Thr182 is oriented to form hydrogen bonds with
the backbone amide of Ala185 (Figure 1C).1 Based on this
model, it was proposed that M182T stabilizes the protein by
forming a hydrogen bond between its side chain and an
unfulﬁlled backbone donor at the end of helix 9 in a classic N-
capping interaction. In all likelihood, both of these structures are
present at thermal equilibrium, but it is impossible to conclude
which, if either, of these interactions plays a dominant role in
stabilizing TEM from the crystallographic data.
Here, we employ Markov state models (MSMs)8−10 to
understand how M182T shifts the distribution of diﬀerent
structures that TEM adopts. These models provide a quantitative
description of a protein’s thermodynamics and kinetics by
deﬁning its structural states and the rates of transitioning
between them. We have previously compared MSMs of variants
that alter TEM’s speciﬁcity to understand how they change the
protein’s function.11 In this study, we compare MSMs of the
wild-type and M182T variants to infer how M182T stabilizes
TEM. We then predict the eﬀects of other mutations, including
new global suppressor mutations, and experimentally test our
predictions using a combination of spectroscopic measurements
of protein stability, nuclear magnetic resonance (NMR)
measurements of chemical shifts, a crystal structure, and in vivo
measurements of the ﬁtness of bacteria expressing our newly
designed TEM variants.
■ RESULTS AND DISCUSSION
M182T Stabilizes the Native State. Uncertainty over
whether M182T stabilizes the native state or destabilizes the
intermediate stems from the limited ability of any one
spectroscopic observable to clearly distinguish all three
thermodynamic states. For example, circular dichroism (CD)
fails to adequately capture M182T’s intermediate state. By CD,
there are three distinguishable states for wild-type5 but only two
for M182T4 (Figure 2A); however, the dependence of M182T’s
native-state stability on denaturant, as reﬂected in its m value, is
shallower than expected for a protein of its size.12 This indicates
that, like wild-type, M182T likely populates more than two states
at equilibrium,13 rendering a two-state model insuﬃcient.
Fluorescence also fails to capture all three thermodynamic states
for both wild-type and M182T (Figure 2B). Previous studies of
β-lactamases have established that the intermediate state has the
same ﬂuorescence as the unfolded state,14 so ﬂuorescence
captures only the transition between the native and intermediate
states.
To overcome the limitations of a single spectroscopic
observable, we performed global ﬁts to the ﬂuorescence and
CD data for each variant, assuming that the ﬁrst transition
observed by CD is the same as that observed by ﬂuorescence.
Figure 1. Representative structures of TEM that highlight two potential
mechanisms for stabilization by Thr182. (A) Crystal structure of TEM
with mutation M182T (PDB 1JWP). The backbone of the α-helix
domain (cyan), β-sheet domain (gray), and s2h2 loop (orange) are
represented as a cartoon. Active site residue, Ser70, and the stabilizing
mutation, Thr182, are shown in sticks. (B) A representative structure of
the ﬁrst mechanism, observed in MD simulations, where Thr182
hydrogen-bonds to the s2h2 loop. (C) A representative structure of the
second mechanism, observed in MD simulations, where Thr182 caps
helix 9.
Figure 2. Chemical melts of TEM. Shown are the fractions of folded
protein for wild-type TEM (black) and TEM M182T (orange) as a
function of [urea]. (A) Monitoring circular dichroism signal. (B)
Monitoring intrinsic ﬂuorescence at 340 nm.
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Doing so allows us to disambiguate the two transitions captured
by CD by leveraging the single transition captured by
ﬂuorescence. Our global ﬁts reveal that M182T stabilizes the
native state without destabilizing the intermediate. The free
energy diﬀerence between the native and intermediate states of
M182T is 3.3 kcal/mol greater than that for wild-type (Table 1).
In contrast, the free energy diﬀerences between the intermediate
and unfolded states are the same, within error, for both variants.
M182T Stabilizes Helix 9. Given our assumption that
M182T does not aﬀect the unfolded ensemble and, thus,
primarily stabilizes the native state, we reason that it should be
possible to infer the mechanism of stabilization from analysis of
native-state ensembles. To accomplish this, we use MSMs to
Table 1. Stabilities of TEM β-Lactamase Variantsa
ΔGun (kcal mol−1) mun (kcal mol−1 M−1) ΔGinb (kcal mol−1) minb (kcal mol−1 M−1) ΔGuib (kcal mol−1) muic (kcal mol−1 M−1)
wild-type 14.3 ± 0.3 3.8 ± 0.2 6.0 ± 0.1 2.1 ± 0.1 8.3 ± 0.1 1.7 ± 0.1
M182T 17.7 ± 0.4 4.1 ± 0.2 10.0 ± 0.6 2.4 ± 0.2 7.8 ± 0.2 1.7, ﬁxed
M182S 18.5 ± 0.5 4.4 ± 0.1 10.6 ± 0.5 2.7 ± 0.1 7.9 ± 0.4 1.7, ﬁxed
M182V 13.5 ± 0.3 3.8 ± 0.1 5.4 ± 0.2 2.1 ± 0.1 8.2 ± 0.1 1.7, ﬁxed
M182N 13.7 ± 0.5 3.8 ± 0.1 5.9 ± 0.4 2.1 ± 0.1 7.8 ± 0.4 1.7, ﬁxed
aAll measurements were repeated three times. Errors are standard deviations. bDetermined using a global ﬁt of ﬂuorescence data to a two-state (I−
N) model and CD data to a three-state (U−I−N) model using the linear extrapolation method (see Methods). cThe value for mui was ﬁxed to the
average value determined for wild-type. The addition of mui as a parameter did not signiﬁcantly improve the quality of the ﬁt, as determined by F-
tests (values in the range of 1 × 10−10 to 1 × 10−7, see Methods).
Figure 3. Eﬀect of M182T on the stability of helix 9, as judged by the distributions of distances between hydrogen-bonding partners. (A) Structure
highlighting hydrogen-bonding partners residue 182 and Met186, Pro183 and Ala187, and Met186 and Leu190, which are colored red. (B−D)
Cumulative distribution functions, calculated from population-weighted statistics from MSMs of our FAST simulations, of the hydrogen-bonding
partners listed in panel A for wild-type (black) and M182T (orange). These plots indicate the probability of observing an atomic distance less than the
speciﬁed value. Our cutoﬀ distance for moderate hydrogen bonds, 2.2 Å, is shown as a dotted line. Probabilities of moderate hydrogen bonds for each
pair are shown in the inset. (E, F) Representative structures, from our MSMs, of helix 9 with a moderate hydrogen bond (observed in M182T) and a
broken hydrogen bond (observed in wild-type). The backbone of the α-helix domain (cyan) and β-sheet domain (gray) are represented as a cartoon.
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provide an atomically detailed representation of conformational
heterogeneity in the native state that is currently unavailable to
many experimental techniques. Doing so enables us to quantify
the probabilities of various interactions in a manner that is not
possible with the static structures from techniques like
crystallography. Furthermore, by identifying interactions that
are formed in M182T’s native-state ensemble but not that of
wild-type TEMwe can narrow down the secondary eﬀects of this
mutation.
To eﬃciently identify the interactions that Thr182 forms, we
employed our FAST simulation method15,16 to build MSMs of
the wild-type and M182T variants of TEM. FAST is a goal-
oriented adaptive sampling method in which we (1) run a batch
of simulations, (2) build an MSM from all the simulation data
collected so far, (3) rank each state with a function that favors
states that optimize some geometric criteria, as well as a statistical
criterion that favors poorly sampled states, (4) run a new batch of
simulations from the highest ranked states, (5) repeat steps 2−4
for some number of iterations, and (6) build a ﬁnal MSM from all
the simulation data. For this study, we sought to maximize the
RMSD from the starting structure to maximize the number of
diﬀerent structures identiﬁed by the ﬁnal model. We have
previously established that FAST captures rare events with
orders of magnitude less simulation data than conventional
molecular dynamics simulations.15 Therefore, the 6.5 μs of
simulation data we collected for each variant should be suﬃcient
to construct a quantitatively predictive map of the native-state
ensemble.17
Analysis of our FAST simulations reveals that M182T prefers
to act as an N-terminal capping residue to helix 9. This
conclusion comes from quantifying the probabilities of all the
diﬀerent contacts Thr182’s side chain can form. Doing so reveals
that Thr182 predominantly caps helix 9 by forming a hydrogen
bond with Ala185 with a probability of 0.72 ± 0.02. Thr182 also
forms a hydrogen bond with the backbone carbonyl of Glu64
with a probability of 0.12 ± 0.02. Thus, we observe both
conformations captured in the two competing crystal structures.
The probabilities of other contacts, such as the hydrogen bond
with the backbone carbonyl of Glu63, are negligible.
While it is tempting to conclude that capping is suﬃcient for
global stabilization, we instead propose that the stability of helix 9
is a better predictor of TEM’s stability. Our model’s distinction
between capping and helix stability was motivated by the
observation that other residues capable of N-capping have not
been observed at position 182 either in clinical isolates or in
directed evolution studies.2 It might seem intuitive that capping
would stabilize helix 9, but, in the next section, we defy this
intuition by identifying a residue that caps without conferring
global stabilization. Previous work on the folding of β-lactamases
provides a foundation for our model by suggesting that the α-
helix domain is largely folded in the intermediate state but the β-
sheet domain is unstructured.18 Taking inspiration from this
model, we propose that helix 9 is unstructured in the
intermediate state. In our model, M182T stabilizes helix 9’s
native conformation and reduces its conformational hetero-
geneity. Because this helix is an important part of the interface
between the α-helix and β-sheet domains, we propose that
stabilizing the helix stabilizes the entire interface between the two
domains, thereby stabilizing TEM’s native conformation. Helix 9
being unstructured in the intermediate state in our model is
consistent with the fact that the free energy diﬀerence between
the unfolded and intermediate states is unaﬀected by M182T
(Table 1).
As a proxy for assessing the stability of helix 9, we quantify the
distribution of distances between its backbone hydrogen-
bonding partners. These distance distributions are population-
weighted statistics of representative conformations from each
state in the MSMs we built from our FAST simulation data sets,
and they capture transitions between weak and moderate
hydrogen bonds. Following past work,19,20 we deﬁne a moderate
hydrogen bond as having a hydrogen bond acceptor to hydrogen
distance less than 2.2 Å, where a weak hydrogen bond has a
distance between 2.2 and 2.5 Å. Assuming that weak hydrogen
bonds are more likely to break on longer time scales, we can infer
M182T’s eﬀect on helix stability by comparing the local
ﬂuctuations of its hydrogen bonds to that of wild-type.
Quantifying the distance distributions of hydrogen bonds
reveals that M182T stabilizes helix 9. M182T increases the
probability of moderate strength hydrogen bonds between three
pairs of residues: 182−186, 183−187, and 186−190 (Figure 3).
As stated above, since moderate strength hydrogen bonds are less
likely to break, we conclude that they are stabilizing. The
distributions for other hydrogen bonds are not altered
signiﬁcantly by the M182T substitution. Interestingly, all the
residues with increased hydrogen-bonding strength reside on the
face of the helix that points into the core of the protein, along the
interface between the two domains (Figure 3A).
Helix Capping Alone Is Not Suﬃcient To Stabilize the
Native State. Mutagenesis at position 182 presents a valuable
opportunity to test our model and probe why other mutations
may or may not stabilize helix 9. In particular, studying other
capping residues could reveal that capping is suﬃcient for
stabilization or, alternatively, lead to the identiﬁcation of other
stabilizing factors. To discover these factors, we modeled
mutations at position 182, predicted their stability relative to
wild-type, and performed experimental tests.
We selected three alternative substitutions at position 182 to
study. First, we selected M182N because asparagine is the most
frequently observed N-capping residue in proteins with known
structures21 and the most stabilizing,22 so one might expect it to
be even more stabilizing than threonine. Second, we chose
M182S because serine has a hydroxyl group that is analogous to
threonine’s, so it might form a similar capping interaction and
have a comparable eﬀect on stability. Third, we modeled M182V
because valine mimics threonine sterically but lacks the ability to
cap since it has a methyl group instead of a hydroxyl group.
Therefore, comparing M182V with the other substitutions could
help elucidate the relative importance of capping and sterics.
Consistent with our expectations, MSMs predict that M182S
and M182N cap helix 9 (Figure S1). The probabilities that
Ser182 and Asn182 cap by hydrogen bonding with Ala185 are
0.61 ± 0.02 and 0.79 ± 0.02, respectively. Each residue can also
hydrogen bond with Glu64 in the s2h2 loop. M182S forms this
interaction with a probability of 0.22 ± 0.02, and M182N forms
this interaction with a probability of 0.59 ± 0.03. Notably,
M182N has the ability to simultaneously cap helix 9 and interact
with the s2h2 loop. Therefore, if capping were suﬃcient to
predict helix stability, we would expect that M182S and M182N
would be stabilizing mutations, while M182V would not.
Quantifying the degree to which each of these substitutions
stabilizes helix 9 suggests that capping is not suﬃcient to stabilize
TEM. Comparing the probabilities of moderate hydrogen bonds
along the length of helix 9 reveals that M182S is predicted to be
stabilizing, whereas M182V and M182N are not (Figure S2).
The fact that M182N is not predicted to be stabilizing is
particularly surprising given that it caps as frequently as M182T
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and can simultaneously hydrogen bond with Glu64. If true, this
would highlight the predictive power of our model, since it deﬁes
biochemical intuition. To test these predictions, we exper-
imentally measured the stability of each TEM variant.
Free energy diﬀerences of each variant, derived from chemical
melts, and a crystal structure are consistent with our model for
global stability. As predicted, M182S stabilizes TEM to a similar
extent to M182T (Table 1, Figure S3). Furthermore, M182N
and M182V are not stabilizing. To provide additional evidence
that M182N caps helix 9 without conferring stability, we solved a
crystal structure of this variant to 2.0 Å resolution (Figure S4,
Table S1). This structure further supports our prediction that
Asn182 caps, since the X-ray density around position 182 is best
ﬁt with a rotamer that caps helix 9 by hydrogen bonding with
Ala185 (Figure S4). Additionally, the mutation M182N
minimally aﬀects nearby residues, as is evidenced by the
RMSD to the wild-type crystal structure (PDB 1BTL) for
backbone residues within 1.0 nm of position 182 being 0.45 Å.
This suggests that stabilization (or destabilization) arises from
changes to the probabilities of diﬀerent states rather than the
identity of the ground state.
Understanding whyM182N does not stabilize TEMdespite its
strong propensity for capping helix 9 presents a valuable
opportunity for dissecting the mechanisms of stabilization by
M182T and M182S. Given that capping is generally stabilizing,
we reasoned that Asn182 must form other interactions that
counterbalance this eﬀect. If this is true, we would expect the
stability of helix 9 in isolation from the rest of the protein to
correlate with the propensity of residue 182 to cap the helix. To
test this prediction, we simulated helix 9 (residues 181−197)
with each of the following residues at position 182: threonine,
serine, asparagine, valine, and methionine. For each variant, we
ran 20 simulations of 200 ns, for a total of 4 μs.
Probing the helical propensity of each variant suggests that
capping is suﬃcient to stabilize helix 9 in isolation. We quantify
helical propensity by measuring the probability that at least 80%
of the residues adopt a conformation in the α-helical region of the
Ramachandran plot. We ﬁnd that each of the helix 9 variants with
an N-terminal capping residue (Thr, Ser, or Asn) at position 182
have a similar helical propensity of ∼45% (Figure S5).
Furthermore, variants that lack a capping residue have much
lower helical propensity (12−23% for Val and Met). These
trends remain the same if the cutoﬀ for considering a structure
helical is changed. Therefore, it appears that any capping
interaction will stabilize helix 9 in isolation, consistent with our
hypothesis that Asn182 must be forming other destabilizing
interactions in the context of the full-length protein. To
determine the reason that M182N does not stabilize helix 9 in
the context of the full sequence, we next examine the diﬀerences
in Asn182’s conformations between the full-length sequence and
the isolated helix.
In both sets of simulation for M182N, the isolated helix and
the full-length sequence, Asn182 largely populates only two
conformations. These conformations diﬀer in whether the χ1-
angle is in the gauche+ (χ1: 0° → 120°) or trans (χ1: 120° →
240°) rotamer. Both conformations are capable of capping helix
9, but only the trans rotamer hydrogen-bonds with Glu64
(Figures 4A and 4B). In the isolated helix, Asn182 adopts the
trans rotamer with a probability of 0.75 ± 0.01, while the
probability of this conformation is only 0.58± 0.03 in the context
of the full-length protein (Figure 5). In contrast, Thr182 and
Ser182 overwhelmingly adopt the gauche+ rotamer (Figure S6).
Asn182’s rotamer populations suggest that the trans rotamer
stabilizes helix 9 but that competing interactions in the context of
the full-length protein mitigate these stabilizing eﬀects by
Figure 4. Two commonly observed side chain conformations of Asn182 in MSMs, which can be characterized by their χ1 angle. (A) A representative
structure with Asn182 in the gauche+ conformation. The side chain amine points out into solution. (B) A representative structure with Asn182 in the
trans conformation. The side chain amine hydrogen-bonds with Glu64 in the s2h2 loop. In both conformations, the side chain hydrogen-bonds with
Ala185. The backbone of the α-helix domain (cyan) and β-sheet domain (gray) are represented as a cartoon.
Figure 5. Asn182 rotamer populations for the full protein and isolated
helix. Shown are the gauche+ (black) and trans (red) rotamer
populations from MSMs of the full protein and isolated helix.
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favoring the gauche+ conformation. As a test of this hypothesis,
we calculated two sets of distance distributions for hydrogen
bonds along helix 9: one for the set of conformations when
Asn182 is in the trans rotamer, and one for the gauche+ rotamer
(Figure S7). Comparing these distributions conﬁrms that the
trans rotamer stabilizes helix 9 by increasing the probability of
moderate strength hydrogen bonds, while the gauche+ rotamer
behaves more like wild-type. We next examined structures from
each rotameric state of Asn182 to understand why gauche+
appears so frequently given that it does not stabilize helix 9.
We ﬁnd the trans and gauche+ conformations of Asn182 to
have distinct eﬀects on packing at the interface between the α-
helix and β-sheet domains. In the gauche+ state, which does not
stabilize helix 9, the domain interface is well-packed (Figure 6A).
In contrast, when Asn182 adopts the trans conformation, it
appears to disrupt the packing of this interface and increase the
exposure of a number of hydrophobic moieties to solvent (Figure
6B). Speciﬁcally, a pocket forms between Tyr46 and Ile47 from
the β-sheet domain, Pro62 and Glu63 of the s2h2 loop, and
Pro183 and Ala184 of the α-helix domain. To quantify this eﬀect,
we calculated the average solvent accessible surface area of these
residues for the ensembles of structures where Asn182 adopts
either the trans or gauche+ rotamer. Doing so reveals that when
Asn182 adopts the trans state, this surface area increases by
∼20% compared to when Asn182 is in the gauche+ state (Figure
S8). Furthermore, much of the increased surface area is
contributed by hydrophobic portions of these residues. Since
exposure of buried hydrophobic groups is thermodynamically
destabilizing, we propose that opening of this pocket counter-
balances the stabilizing eﬀects of capping. Therefore, M182N
fails to stabilize helix 9 and ultimately the entire protein. This
result is also consistent with the observation of the gauche+
rotamer in the crystal structure of M182N, since each rotamer
has roughly equal population and crystal packing forces will favor
the more compact structure. Finally, our results for Asn182 are
consistent with our proposal that the domain interface is a crucial
determinant of the stability of TEM’s native state.
Stabilizing Mutations Stabilize the Domain Interface.
As a further test of our model, and the importance of helix 9 to
the domain interface, we turned to NMR spectroscopy. We use
NMR because it can provide site speciﬁc details on protein
structure and dynamics. Here, we performed 1H−15N hetero-
nuclear single quantum coherence (HSQC) experiments for
each variant and calculated chemical shift perturbations (CSPs)
relative to wild-type. Since each chemical shift reports on a
nucleus’s unique local magnetic environment, a CSP indicates a
change in the structure and dynamics at this site. Thus, the CSPs
for each variant will identify all regions aﬀected by the mutation,
regardless of their proximity to the mutation.
Consistent with our proposed mechanism for stabilization,
most of the statistically signiﬁcant CSPs for M182T are found in
helix 9 and the adjacent β-sheets (Figure 7). Signiﬁcant CSPs are
observed on the ﬁrst two turns of helix 9, as is expected from our
prediction that M182T increases the propensity of moderate
hydrogen bonds.We also observe signiﬁcant CSPs on the β-sheet
domain, not only in residues that interact directly with helix 9
(i.e., Ile47, Leu49, and Val262) but also in more distant residues
(i.e., Val44, Phe60, and Thr265). Together, these results
demonstrate that M182T alters the structure and dynamics of
helix 9 and that these eﬀects are propagated to distant residues
along the domain interface. This is consistent with our model
that M182T stabilizes helix 9, which in turn stabilizes the
interface between the β-sheet and α-helix domains. To explore
this idea further we next examined the CSPs of the other variants.
Comparing the magnitude and direction of CSPs on the β-
sheet between each variant suggests that stabilizing mutations
stabilize the domain interface. Similar to M182T, each variant
predominately displays CSPs on helix 9 and the interface of the
α-helix and β-sheet domains (Figure S9). This indicates that each
of our substitutions at position 182 alters the structure and
dynamics of the domain interface. Although one might conclude
from the common locations of CSPs between the variants that
each mutation perturbs TEM in a similar manner, we ﬁnd that
the magnitude of CSPs on the β-sheet diﬀers between variants
Figure 6. Representative structures that highlight the eﬀects of diﬀerent Asn182 rotamers on packing at the interface of the s2h2 loop and α-helix/β-
sheet domains. (A) A representative structure of the gauche+ rotamer. (B) A representative structure of the trans rotamer. Residues whose packing is
aﬀected by Asn182’s rotamer (Tyr46, Ile47, Pro62, Glu63, Pro182, and Ala184) are shown as red spheres. The backbone of the α-helix domain (cyan)
and β-sheet domain (gray) are represented as a cartoon.
Figure 7. Backbone amide chemical shift perturbations of TEMM182T.
The backbone of the α-helix domain (cyan) and β-sheet domain (gray)
are represented as a cartoon. Residues with statistically signiﬁcant
chemical shift perturbations are colored red.
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(Figure 8). Additionally, these CSPs are not randomly scattered.
Instead, there is a clear trend from the least stable to the most
stable variant. Taking all of our observations together, we
propose that CSPs closer to wild-type represent a more loosely
packed, weaker interface, whereas those closer to M182T/
M182S represent a more tightly packed, stronger interface.
Therefore, we conclude that global stability is achieved not only
through helix 9 stabilization but also through stabilization of the
domain interface.
Stabilizing Mutations Are Global Suppressors. If
stabilization by M182T is the biophysical mechanism for its
ability to suppress the impact of other deleterious mutations,
then we would expect the stabilities of the three new variants we
selected to correlate with their ability to act as global suppressors.
To test this hypothesis, we introduced our three substitutions
into a background that also contains the substitution G238S.
G238S is known to confer TEMwith cefotaxime resistance at the
expense of protein stability.1,2,5 Furthermore, a variant with both
G238S and M182T is more resistant to cefotaxime than a variant
with just one of these substitutions. Therefore, we expect
M182S/G238S to have similar levels of cefotaxime resistance to
M182T/G238S while we expect M182N/G238S and M182V/
G238S to have similar levels of cefotaxime resistance to G238S
alone.
Minimal inhibitory concentrations (MICs) of bacteria
expressing our TEM variants in the background of G238S in
the presence of varying levels of cefotaxime reveal that global
stabilization of the domain interface leads to global suppression.
As predicted, M182S/G238S resembles M182T/G238S while
the other variants are more similar to G238S alone (Table 2).
The observation that M182S is a global suppressor mutation that
has not been reported previously led us to question if other global
suppressors may exist.
Figure 8. Representative backbone amide chemical shifts, located on TEM’s β-sheet, for 5 sequence variants. Shown are the chemical shifts for wild-type
(black), M182V (blue), M182N (purple), M182S (green), and M182T (orange) for residues located on the β-sheet: Val44, Ile47, Leu49, Phe60, and
Val262. For reference, Glu212 is not located on the β-sheet and does not display signiﬁcant perturbations upon mutation.
Table 2. MICs for Escherichia coli Strains Expressing TEM β-
Lactamase Variantsa
cefotaxime (μM)
single mutant double mutant (+G238S)
























aMIC determination was performed in triplicate. Values are most
commonly observed concentration with an error of ± one well, which
diﬀer by 2-fold in concentration. bNot determined.
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MICs for every other possible variant at position 182, in
combination with G238S, reveal that there are no other possible
global suppressor mutations at this position (Table 2).
Substituting Met182 with valine, asparagine, cysteine, or alanine
in a G238S background is neutral. All other double mutants have
lower MICs than G238S alone, suggesting that they are
deleterious. Therefore, M182T and M182S are the only global
suppressor mutations at this residue. Together with the previous
sections, these results are consistent with our hypothesis that
stabilization of helix 9 and the domain interface are responsible
for M182T’s ability to stabilize TEM and suppress the eﬀects of
other destabilizing substitutions.
■ CONCLUSIONS
Our MSMs have provided a new mechanistic understanding of
the stabilizing eﬀects of M182T, which we successfully use to
predict the eﬀects of new mutations at position 182. Previous
crystallographic studies have proposed that M182T’s stabilizing
eﬀect is a result of Thr182 either N-capping or forming a
hydrogen bond between the α-helix and β-sheet domain
interface. Since MSMs are able to capture conformational
heterogeneity in a way that cannot be inferred from static
structures, we are able to propose that M182T stabilizes helix 9,
which in turn stabilizes the interface between the α-helix and β-
sheet domains. In support of the validity of our model, it has
superior predictive power compared to previous models: we
correctly predict that M182S is stabilizing but not M182V and
M182N, whereas the hydrogen-bonding model incorrectly
predicts M182N to be stabilizing. Furthermore, NMR chemical
shift perturbations support our dynamical predictions. The fact
that our MSMs make successful predictions that defy
biochemical intuition is a strong testament to the accuracy and
value of these atomically detailed models.
The ability to predict new stabilizing mutations is an important
step toward designing proteins with new or improved functions.
The fact that M182S has not been observed suggests that nature
has not exhaustively identiﬁed all possible stabilizing mutations.
Our work raises interesting questions, such as why M182S has
not been observed in nature. Furthermore, combining our ability
to predict new stabilizing mutations with our previous work on
predicting howmutations impact activity could enable the design
of proteins with new or improved function.
■ METHODS
MD Simulations. All simulations were run with Gromacs
5.1.1.23 β-Lactamase simulations were run at 300 K using the
AMBER03 force ﬁeld with explicit TIP3P solvent.24,25 We have
previously shown that the AMBER03 force ﬁeld is suﬃcient to
capture the relevant conformational states of TEM β-lactamases
for a range of problems, including the identiﬁcation of cryptic
pockets, the design of allosteric drugs, and predicting the eﬀects
of mutations.11,26−28 The single starting structure for TEM-1 β-
lactamase simulations was generated from the crystallographic
structure (PDB ID: 1JWP).1 The starting structures for each
TEM variant was generated by mutating the side chain at
position 182 to the respective amino acid using PDBFixer,
followed by an energy minimization for 1,000 steps using the
AMBER03 force ﬁeld with the OBC GBSA implicit solvent
model.24,29,30 Starting structures for the individual helix
simulations were taken as residues 181−197 from the starting
structures of the full sequence. For each full-length sequence, 2.5
μs of conventional sampling and 4 μs of FAST-RMSD adaptive
sampling (described below) were performed. For the individual
helix simulations, 4 μs of each sequence was performed: 20
simulations of 200 ns.
Simulations were prepared by placing the starting structure for
each sequence in a dodecahedron box that extended 1.0 Å
beyond the protein in any dimension. Each system was then
energy minimized with the steepest descent algorithm until the
maximum force fell below 100 kJ/mol/nm using a step size of
0.01 nm and a cutoﬀ distance of 1.2 nm for the neighbor list,
Coulomb interactions, and van der Waals interactions. For
production runs, all bonds were constrained with the LINCS
algorithm and virtual sites were used to allow a 4 fs time step.31,32
Cutoﬀs of 1.0 nm were used for the neighbor list, Coulomb
interactions, and van der Waals interactions. The Verlet cutoﬀ
scheme was used for the neighbor list. The stochastic velocity
rescaling (v-rescale) thermostat was used to hold the temper-
ature at 300 K.33 Conformations were stored every 20 ps.
Adaptive Sampling. The FAST algorithm was used to
generate simulation data.15 FAST-RMSD was run for each
sequence for 10 rounds, of 10 simulations per round, where each
simulation was 40 ns in length: a total of 4 μs per sequence. The
FAST-ranking favored states that maximized the RMSD to the
starting structure. RMSD calculations were performed between
all heavy atoms in residues within 1.0 nm of position 182 in the
crystallographic starting structure. To enhance the conforma-
tional diversity of states that are chosen for reseeding simulations,
the FAST-ranking function was modiﬁed with a term that
penalizes states conformationally similar to others selected. This
ensures that each round of sampling contains a good spread of
conformations. Procedurally, states are selected one at a time,
where the modiﬁed term is recomputed and added to the original
ranking for each selection. The modiﬁed ranking takes the form
ϕ αψ βχ= ̅ + ̅ +ϕr i i i i( ) ( ) ( ) ( )
where ϕ̅ is the directed component, ψ̅ is the undirected
component, and α and β control the weights of ψ̅ and χ
respectively. Here, ψ̅(i) is taken to be the state counts and a value
























is calculated as the average of Gaussian weighted RMSDs from
state i to theN states that have been selected for reseeding so far,
where w is the Gaussian width (set to the clustering radius).
Thus, the procedure for selecting states to reseed simulations
from each round is as follows: (1) rank all states by the FAST-
ranking and select the top state as the ﬁrst state to reseed, (2) add
the similarity penalization term to the FAST-ranking and select
the top state as another state to reseed, and (3) update the
penalization term and repeat step 2 until the desired number of
states for reseeding have been selected.
MSM Construction and Analysis. All MSMs were built
using MSMBuilder.34,35 An MSM is a network representation of
an energy landscape, where nodes are discrete conformational
states and directed edges are conditional transition probabilities.
MSMs provide a statistically rigorous way of mapping of protein
dynamics, even from parallel simulations with starting structures
that are not Boltzmann distributed. Using an MSM, we can
quantify thermodynamic and kinetic changes that aid in
understanding molecular motions.
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Simulation data sets for each TEM variant were combined and
clustered into a single shared state-space. Each data set consisted
of 4 μs FAST-RMSD and 2.5 μs conventional simulations.With 5
sequences, this gives a total of 32.5 μs of total simulation. The
shared state-space was deﬁned using all heavy atoms on residues
within 1.0 Å of position 182 in the crystallographic structure of
TEM β-lactamase (PDB ID: 1JWP). The side chain atoms of
position 182 were not included, since they vary between
sequences. These atomic coordinates were then clustered with
a k-centers algorithm based on RMSD between conformations
until every cluster center had a radius less than 1.0 Å. Then, 10
sweeps of a k-medoids update step was used to center the clusters
on the densest regions of conformational space. Following
clustering, the cluster assignments were split and a unique MSM
was constructed for each TEM sequence with a lagtime of 2 ns.
To obey microscopic reversibility, transition count matrices were
symmetrized. Representative cluster centers were saved for each
state in each sequence for analysis.
Geometric analysis of representative cluster centers was
performed using MDTraj:36 in particular, RMSDs, solvent-
accessible surface areas, and atomic distances. Ensemble average
values withinMSMswere calculated as the expectation value for a
particular observable. I.e., the expectation of observable Z is
calculated as
∑=E Z p z z[ ] ( )
i
i i
where p(zi) is the population of state i and zi is the value of state i.
All cumulative distribution functions were generated with
population-weighted statistics of representative conformations
from each state in the MSMs we built from our FAST simulation
data sets. Each point in one of these cumulative distribution
functions is calculated as
∑=
≤




where p(zi) is the population of state i.
Protein Expression and Puriﬁcation. TEM-1 was
subcloned using NdeI and XhoI restriction sites into the multiple
cloning site of a pET24 vector (Life Technologies), and its native
export signal sequence was replaced by the OmpA signal
sequence to maximize export eﬃciency. Site-speciﬁc variants
were constructed via site-directed mutagenesis and veriﬁed by
DNA sequencing. Plasmids were then transformed into
BL21(DE3) Gold cells (Agilent Technologies) for expression
under T7 promoter control.
Cells were induced with 1mM IPTG at OD= 0.6 and grown at
18 °C for 15 h before harvesting. TEM β-lactamases were
isolated from the periplasmic fraction using osmotic shock lysis:
Cells were resuspended in 30 mM Tris pH 8, 20% sucrose and
stirred for 10 min at room temperature. After centrifugation, the
pellet was resuspended in ice-cold 5 mM MgSO4 and stirred for
10min at 4 °C. After centrifugation, the supernatant was dialyzed
against 20 mM sodium acetate, pH 5.5, and puriﬁed using cation
exchange chromatography (BioRad UNOsphere Rapid S
column) followed by size exclusion chromatography (BioRad
ENrich SEC 70 column) into storage buﬀer (20 mM Tris, pH
8.0).
Protein Stability Measurements. Fluorescence data were
collected using a Photon Technology International Quanta-
Master 800 rapid excitation spectroﬂuorometer with Quantum
Northwest Inc. TC-125 Peltier-controlled cuvette holder. Melts
were performed by monitoring intrinsic protein ﬂuorescence,
exciting at 280 nm and detecting emission intensity at 340 nm.
Melts were carried out in a 1 cm path length cuvette (50 μg/mL
protein, 20 mMTris pH 7). Samples with varying concentrations
of urea were prepared individually, equilibrated overnight, and
stirred in the instrument for 2 min before data collection.
Circular dichroism data were collected using an Applied
Photophysics Chirascan with a Quantum Northwest Inc. TC-
125 Peltier-controlled cuvette holder. Melts were performed by
monitoring the CD signal at 222 nm and were carried out in a 1
cm path length cuvette (50 μg/mL protein, 20 mM Tris pH 7).
For urea melts, samples with varying concentrations of urea were
prepared individually, equilibrated overnight, and stirred in the
instrument for 2 min before data collection, which was averaged
over 60 s.
Urea melt data for each variant were globally ﬁt. Fluorescence
data were ﬁt by a two-state model (I-to-N), and CD data
simultaneously were ﬁt by a three-state model (U-to-I-to-N)
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where Fi and Fn are the ﬂuorescence signals for the intermediate
and native states, ﬁt as lines, andΘu,Θi, andΘn are the CD signals
for the unfolded, intermediate, and native states, ﬁt as lines.ΔGin
is the extrapolated free energy of folding relative to the
intermediate in the absence of denaturant, and min is a
proportionality constant related to the steepness of the I-to-N
transition. ΔGui and mui are the free energy and m-value
describing the U-to-I transition.
Themui-value was ﬁxed to 1.7 kcal/mol·M, the average derived
for wild-type TEM, because we hypothesize that the intermediate
species is the same between variants. m-values correlate with the
change in solvent-exposed surface area upon folding12 and are
characteristic of a particular folded or partially folded state. For
comparison, all data were also ﬁt using a ﬂoatingmui-value, and F-
tests were performed with the null hypothesis that any
improvement to the ﬁt due to the additional parameter occurs
by chance. The F-values obtained were all in the range of 1 ×
10−10 to 1 × 10−7 (much lower than ∼4.2, the critical F-value for
p < 0.05), and thus the F-tests strongly support our hypothesis
that holding the mui-value ﬁxed is reasonable.
Minimal Inhibitory Concentration (MIC) Measure-
ments. Levels of antibiotic resistance of BL21(DE3) cells
containing TEM expression plasmids were determined by
measuring their minimum inhibitory concentrations (MIC90s)
using the broth microdilution method according to the Clinical
and Laboratory Standards Institute (CLSI, formerly the
NCCLS) guidelines.38 Strains were grown to saturation
overnight in Luria Miller broth with kanamycin and 1 mM
IPTG. Each well of a 96-well microtiter plate was ﬁlled with 50
μL of sterile Mueller Hinton II (MHII) medium broth (Sigma).
Antibiotic was dissolved in water making a 20 mM solution and
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then diluted with sterile MHII medium broth to 288 μM
cefotaxime (CFX). Exactly 50 μL of the compound solution was
added to the ﬁrst well of the microtiter plate, and 2-fold serial
dilutions were made down each row of the plate. Exactly 50 μL of
bacterial inoculum (diluted to 5 × 105 CFU mL−1 from the
overnight cultures) was then added to each well, giving a total
volume of 100 μL well−1 and compound concentration gradients
of 72−0.04 μMCFX. The plate was incubated at 37 °C for 17 h,
and then each well was examined for bacterial growth. The
MIC90 was recorded as the lowest compound concentration
required to inhibit 90% of bacterial growth as judged by turbidity
of the culture medium relative to a row of wells ﬁlled with a water
standard. Gentamicin was included in a control row at a
concentration gradient of 174−0.09 μM.
Nuclear Magnetic Spectroscopy. Uniform 15N labeled
TEM-1 was expressed in M9 minimal medium containing
15NH4Cl (1 g/L), D-glucose (4 g/L), and 2.5 mM betaine. The
cells were incubated at 37 °C and 240 rpm until OD600 ≫ 0.6,
and then for an additional 30 min at 18 °C and 225 rpm. Cells
were induced with IPTG and incubated approximately 36 h prior
to harvesting. Protein was puriﬁed from both the periplasm and
the medium; the medium was concentrated to approximately
100 mL using an Amicon stirred cell (EMD Millipore) and
dialyzed overnight into TEM-1 S loading buﬀer. Puriﬁcation
followed the periplasmic prep.
15N/1H HSQC spectra were recorded at 303 K on a 600 MHz
(1H) Bruker Avance III spectrometer. TEM-1 samples were
concentrated to 100 μM in 25 mM sodium phosphate, 4 mM
imidazole pH 6.6, and 10% D2O. Wild type TEM-1 assignments
were previously reported (BMRB entry 16392).39
X-ray Crystallography. Screening for crystal growth
conditions was performed with Mosquito (TTP LabTech
Limited) using 25 mg/mL protein. Optimized crystals were
grown via hanging drop vapor diﬀusion at 18 °C by mixing 1 μL
of protein at 25 mg/mL with 1 μL of reservoir containing 0.1 M
sodium phosphate dibasic/citric acid pH 4.2, 0.1 M lithium
sulfate, and 20% PEG 1000. Crystals were cryoprotected in oil
(Hampton Research Parabar 10312 HR2-862) before ﬂash-
freezing in liquid nitrogen. X-ray diﬀraction data was collected at
beamline 4.2.2 of the Advanced Light Source in Berkeley, CA,
and processed with XDS.40 Phase determination was by
molecular replacement using PHENIX41 with the coordinates
from PDB 1JWP used as a search model. Iterative model building
in COOT42 and reﬁnement with PHENIX41 accounting for
crystal twinning led to the current model of M182N with Rwork/
Rfree of 22.46%/28.26%. The ﬁnal reﬁned model had a
Ramachandran plot with 96.54% of residues in the favored
region and none in the disallowed region (MolProbity).43 A
summary of the data collection and reﬁnement statistics is shown
in Table S1. Structure factors and coordinates are deposited in
the RSCB Protein Structure Database under PDB ID 6B2N.
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